NATIONAL HEALTH INVESTORS INC Insider Trading Activity

National Health Investors Inc. director reports multiple stock option exercises and share withholding on December 9, 2025.

Accepted by SEC EDGAR 12/11/2025 - 04:59 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

National Health Investors Inc. director reports multiple stock option exercises and share withholding on December 9, 2025. The reporting person, acting as trustee, exercised several stock options, acquiring 25,000 shares of common stock at an exercise price of $69.2, another 25,000 shares at $53.41, and three additional blocks of 10,000 shares each at exercise prices of $54.73, $57.76, and $73.34. All of these were coded as option exercises. The filing also shows a transaction coded "F" in which 62,827 shares of common stock were disposed of at $78.37, leaving 127,358 shares of common stock beneficially owned indirectly as trustee after the reported transactions.

Insider Trade Summary

80,000 shares exercised/converted

Exercise 11 txns

Insider SWAFFORD CHARLOTTE A

Role Director

Type	Security	Shares	Price	Value
Exercise	Stock Options (Right to Buy) 2-25-2021	25,000	$0.00	$0.00
Exercise	Stock Option (Right to buy) 2022	25,000	$0.00	$0.00
Exercise	Stock Option (Right to Buy) 2023	10,000	$0.00	$0.00
Exercise	Stock Option (Right to Buy) 2024	10,000	$0.00	$0.00
Exercise	Stock Option (Right to Buy) 2025	10,000	$0.00	$0.00
Exercise	Common Stock	25,000	$69.20	$1.73M
Exercise	Common Stock	25,000	$53.41	$1.34M
Exercise	Common Stock	10,000	$54.73	$547K
Exercise	Common Stock	10,000	$57.76	$578K
Exercise	Common Stock	10,000	$73.34	$733K
Exercise Price or Tax Liability	Common Stock	62,827	$78.37	$4.92M

Holdings After Transaction: Stock Options (Right to Buy) 2-25-2021 — 0 contracts (Direct); Stock Option (Right to buy) 2022 — 0 contracts (Direct); Stock Option (Right to Buy) 2023 — 0 contracts (Direct); Stock Option (Right to Buy) 2024 — 0 contracts (Direct); Stock Option (Right to Buy) 2025 — 0 contracts (Direct); Common Stock — 127,358 shares (Indirect, Trustee)

Holdings Before and After: Stock Options (Right to Buy) 2-25-2021, 25,000 to 0 contracts (Direct); Stock Option (Right to buy) 2022, 25,000 to 0 contracts (Direct); Stock Option (Right to Buy) 2023, 10,000 to 0 contracts (Direct); Stock Option (Right to Buy) 2024, 10,000 to 0 contracts (Direct); Stock Option (Right to Buy) 2025, 10,000 to 0 contracts (Direct); Common Stock, 110,185 to 127,358 shares (Indirect, Trustee)

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SWAFFORD CHARLOTTE A

(Last) (First) (Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO TN 37129

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/09/2025		M		25,000	A	$69.2	135,185	I	Trustee
Common Stock	12/09/2025		M		25,000	A	$53.41	160,185	I	Trustee
Common Stock	12/09/2025		M		10,000	A	$54.73	170,185	I	Trustee
Common Stock	12/09/2025		M		10,000	A	$57.76	180,185	I	Trustee
Common Stock	12/09/2025		M		10,000	A	$73.34	190,185	I	Trustee
Common Stock	12/09/2025		F		62,827	D	$78.37	127,358	I	Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy) 2-25-2021	$69.2	12/09/2025		M			25,000	02/25/2021	02/25/2026	Common Stock	25,000	$0	0	D
Stock Option (Right to buy) 2022	$53.41	12/09/2025		M			25,000	02/25/2022	02/25/2027	Common Stock	25,000	$0	0	D
Stock Option (Right to Buy) 2023	$54.73	12/09/2025		M			10,000	02/24/2023	02/24/2028	Common Stock	10,000	$0	0	D
Stock Option (Right to Buy) 2024	$57.76	12/09/2025		M			10,000	02/23/2024	02/23/2029	Common Stock	10,000	$0	0	D
Stock Option (Right to Buy) 2025	$73.34	12/09/2025		M			10,000	03/03/2025	03/03/2030	Common Stock	10,000	$0	0	D

Explanation of Responses:

	/s/ Charlotte A. Swafford	12/09/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.